[Mycobacterium avium infection in a renal transplant recipient].
Valerga
Mario
M
Cugliari
Marcela
M
Cefalo
Eliana
E
Martín
María
M
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001706:Biopsy; D002939:Ciprofloxacin / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004977:Ethambutol / Q000627:therapeutic use; D006505:Hepatitis / Q000382:microbiology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation; D008297:Male; D015269:Mycobacterium avium Complex / Q000302:isolation & purification; D015270:Mycobacterium avium-intracellulare Infection / Q000175:diagnosis* / Q000209:etiology; D014386:Tuberculosis, Hepatic / Q000175:diagnosis; D053706:Typhlitis / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D007166:Immunosuppressive Agents; D002939:Ciprofloxacin; D004977:Ethambutol; D017291:Clarithromycin